) The Biostatistics Core is part of the Biostatistics Support Group (BSG) which has provided research support to the University of Minnesota Blood and Marrow Transplantation Program (BMT) since its inception in the late seventies and core support to the Stem Cell Program Project since 1995. Statisticians provide expertise in the planning and analysis of clinical and laboratory studies. They also supervise a technical staff in the design, maintenance, and data collection of the BMT research database. This comprehensive database contains clinical data on each of the more than 3,000 patients who have received transplants at the University of Minnesota over the past 30 years. The support provided by the Biostatistics Core will continue along the same lines as for the current grant. The services are divided into the following connected Objectives: Objective 1. Statistical Planning and Analysis. To provide statistical expertise in the planning and analysis of clinical trials (projects 2, 3, 4, 5) statistical consultation to researchers carrying out laboratory studies (Projects 1-5, Core D). To provide access to the BMT database for retrieval of suitable clinical data for planning of new studies and to serve as historical controls. Objective 2. Data Collection, Entry, and Quality Assurance. To collect, enter, and quality assure pre- and post-transplant data on donors and patients enrolled in clinical trials of the Program Project. Objective 3. Database Design and Management. To design, maintain, protect the integrity, and update the comprehensive BMT database to accommodate the needs of the Stem Cell Program Project. Maintain and update the reporting and data retrieval system. Objective 4. Maintenance of the Computer Network. To maintain and update the computer network for data entry, connection to the database and connections to the hospital information systems to accommodate the needs of the Program Project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA065493-08
Application #
6652736
Study Section
Project Start
2002-08-26
Project End
2003-05-31
Budget Start
Budget End
Support Year
8
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Sarhan, Dhifaf; Hippen, Keli L; Lemire, Amanda et al. (2018) Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37. Cancer Immunol Res 6:766-775
Williams, Robin L; Cooley, Sarah; Bachanova, Veronika et al. (2018) Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells. Biol Blood Marrow Transplant 24:618-622
Don Yun, Hyun; Felices, Martin; Vallera, Daniel A et al. (2018) Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells. Blood Adv 2:1580-1584
Hippen, Keli L; Loschi, Michael; Nicholls, Jemma et al. (2018) Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease. Front Immunol 9:57
Pennell, Christopher A; Barnum, Jessie L; McDonald-Hyman, Cameron S et al. (2018) Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice. Mol Ther 26:1423-1434
Williams, Shelly M; Sumstad, Darin; Kadidlo, Diane et al. (2018) Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution. Transfusion 58:1458-1467
Mathew, Nimitha R; Baumgartner, Francis; Braun, Lukas et al. (2018) Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med 24:282-291
Romee, Rizwan; Cooley, Sarah; Berrien-Elliott, Melissa M et al. (2018) First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation. Blood 131:2515-2527
Stefanski, Heather E; Jonart, Leslie; Goren, Emily et al. (2018) A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression. PLoS One 13:e0193461
Owen, David L; Mahmud, Shawn A; Vang, Kieng B et al. (2018) Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. J Immunol 200:3926-3933

Showing the most recent 10 out of 395 publications